Overview

Moonwalk Biosciences is a biotechnology company specializing in precision epigenetic medicines, aiming to reprogram cells to their healthy state by targeting the epigenetic code. Co-founded by Alex Aravanis, M.D., Ph.D., and Feng Zhang, Ph.D., the company has developed a novel platform technology providing a comprehensive view of the epigenome in health and disease.

Therapeutic areas

Cardiometabolic DiseasesLiver DiseasesObesity

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Moonwalk Biosciences in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this Moonwalk Biosciences?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.